Published in Proc Natl Acad Sci U S A on December 01, 1990
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol (1995) 5.21
Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J Virol (1992) 3.44
Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J (1999) 2.33
Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution. Proc Natl Acad Sci U S A (1991) 1.46
Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses. J Virol (1995) 1.45
Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein. Protein Sci (1998) 1.45
Application of protein engineering to enhance crystallizability and improve crystal properties. Acta Crystallogr D Biol Crystallogr (2010) 1.38
Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein. Acta Crystallogr D Biol Crystallogr (2009) 0.99
Antibody fragments as tools in crystallography. Clin Exp Immunol (2011) 0.94
Antibody-enabled small-molecule drug discovery. Nat Rev Drug Discov (2012) 0.86
Conversion of scFv peptide-binding specificity for crystal chaperone development. Protein Eng Des Sel (2011) 0.85
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Solvent content of protein crystals. J Mol Biol (1968) 106.07
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
Three-dimensional structure of poliovirus at 2.9 A resolution. Science (1985) 11.47
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature (1989) 5.87
Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science (1986) 4.94
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40
The atomic structure of Mengo virus at 3.0 A resolution. Science (1987) 4.34
Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature (1987) 3.26
Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci U S A (1989) 2.65
Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol (1989) 2.49
Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc Natl Acad Sci U S A (1988) 2.30
Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J Virol (1988) 2.09
Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci U S A (1988) 1.60
Expression in Escherichia coli and purification of human immunodeficiency virus type 1 capsid protein (p24). AIDS Res Hum Retroviruses (1990) 1.40
Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus. Proc Natl Acad Sci U S A (1988) 1.22
Cell surface expression of several species of human immunodeficiency virus type 1 major core protein. J Virol (1989) 1.14
A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites. EMBO J (1989) 1.08
AIDS vaccine predictions. Nature (1987) 1.08
Inhibitors of viral uncoating. Pharmacol Ther (1989) 1.07
Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Acad Sci U S A (1989) 1.04
Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antiviral Res (1990) 1.02
Staphylococcal protein A binding to the Fab fragments of mouse monoclonal antibodies. J Immunol (1984) 0.94
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68
Chemical and biological evolution of nucleotide-binding protein. Nature (1974) 7.39
X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A (2001) 5.83
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol (2005) 5.27
Structure of the bacteriophage phi29 DNA packaging motor. Nature (2000) 5.25
Comparison of super-secondary structures in proteins. J Mol Biol (1973) 4.85
Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40
The atomic structure of Mengo virus at 3.0 A resolution. Science (1987) 4.34
Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature (1991) 4.24
Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol (2000) 4.01
Rotation function calculations with GLRF program. Methods Enzymol (1997) 3.99
Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol (1996) 3.93
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Determining the intensity of Bragg reflections from oscillation photographs. Methods Enzymol (1985) 3.72
Ordering genes in a flagella pathway by analysis of expression kinetics from living bacteria. Science (2001) 3.69
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci U S A (1993) 3.62
Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J Virol (1992) 3.44
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int (2007) 3.17
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A (2002) 3.16
Telling the truth about terminal cancer. JAMA (1998) 3.07
Neutralizing monoclonal antibodies to the AIDS virus. AIDS (1988) 3.06
Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci U S A (1987) 2.99
Titin: major myofibrillar components of striated muscle. Proc Natl Acad Sci U S A (1979) 2.96
Assembly of a tailed bacterial virus and its genome release studied in three dimensions. Cell (1998) 2.91
Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J Virol (1997) 2.81
The structure of coxsackievirus B3 at 3.5 A resolution. Structure (1995) 2.73
Antiviral agent blocks breathing of the common cold virus. Proc Natl Acad Sci U S A (1998) 2.71
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
The locked rotation function. Acta Crystallogr A (1990) 2.65
Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J Virol (1989) 2.61
Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol (1989) 2.49
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47
Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation (2001) 2.46
Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46
Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure (1996) 2.46
Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci U S A (1977) 2.45
Atomic structure of single-stranded DNA bacteriophage phi X174 and its functional implications. Nature (1992) 2.44
Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A (2000) 2.42
Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol (1992) 2.42
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol (1993) 2.39
A retrospective cohort study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1988) 2.38
Structure of beef liver catalase. J Mol Biol (1981) 2.35
Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc Natl Acad Sci U S A (1988) 2.30
Structural constraints of possible mechanisms of lactate dehydrogenase as shown by high resolution studies of the apoenzyme and a variety of enzyme complexes. Cold Spring Harb Symp Quant Biol (1972) 2.23
Exploring structural homology of proteins. J Mol Biol (1976) 2.23
Protein folding. Annu Rev Biochem (1981) 2.21
Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J (1999) 2.17
Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure (1998) 2.17
Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J Virol (1988) 2.09
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
A case-control study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1987) 2.07
Structure, sequence, and function correlations among parvoviruses. Virology (1993) 2.06
Structure and morphogenesis of bacteriophage T4. Cell Mol Life Sci (2003) 2.06
Studies of asymmetry in the three-dimensional structure of lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1975) 2.05
The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. J Biol Chem (1979) 2.03
Structure and assembly of large lipid-containing dsDNA viruses. Nat Struct Biol (2000) 2.00
Encephalopathy and fatty degeneratiof on the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics (1971) 2.00
Structure determination of feline panleukopenia virus empty particles. Proteins (1993) 1.99
Malakoplakia. J Pathol (1983) 1.98
Refined crystal structure of dogfish M4 apo-lactate dehydrogenase. J Mol Biol (1987) 1.98
The active center of catalase. J Mol Biol (1985) 1.97
The role of autolysins during vegetative growth of Bacillus subtilis 168. Microbiology (1998) 1.97
Sarcomas in north west England: I. Histopathological peer review. Br J Cancer (1991) 1.95
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J Virol (1989) 1.92
Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol (2001) 1.91
Structural adaptations of lactate dehydrogenase isozymes. Proc Natl Acad Sci U S A (1977) 1.88
Structure-function relationships in lactate dehydrogenase. Proc Natl Acad Sci U S A (1973) 1.87
Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Lett (1996) 1.87
Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res (2000) 1.86
Structure of a viral procapsid with molecular scaffolding. Nature (1997) 1.85
Structure and self-association of the Rous sarcoma virus capsid protein. Structure (2000) 1.83
The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure (1997) 1.82
Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc Natl Acad Sci U S A (1989) 1.81
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel (2010) 1.80
Climate change and the integrity of science. Science (2010) 1.80
Structure of lactate dehydrogenase at 2-8 A resolution. Nature (1970) 1.78
Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A. J Mol Biol (1990) 1.78
Structure of southern bean mosaic virus at 2.8 A resolution. Nature (1980) 1.78
Physical and biological properties of dengue-2 virus and associated antigens. J Virol (1970) 1.75
Structure determination of the head-tail connector of bacteriophage phi29. Acta Crystallogr D Biol Crystallogr (2001) 1.74
A comparison of the heme binding pocket in globins and cytochrome b5. J Biol Chem (1975) 1.74
The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci U S A (1998) 1.73
Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain. Structure (1997) 1.72
Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol (2000) 1.71
Measuring standards of care for early breast cancer in an insured population. J Clin Oncol (1997) 1.71